Allen C, Thornton P, Denes A et al (2012) Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J Immunol 189:381–392. https://doi.org/10.4049/jimmunol.1200409
Article CAS PubMed Google Scholar
Bederson JB, Pitts LH, Tsuji M et al (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472–476. https://doi.org/10.1161/01.STR.17.3.472
Article CAS PubMed Google Scholar
Bhat M, Pouliot M, Couture R, Vaucher E (2014) The kallikrein-kinin system in diabetic retinopathy. Prog Drug Res 69:111–143. https://doi.org/10.1007/978-3-319-06683-7_5
Brandi E, Torres-Garcia L, Svanbergsson A et al (2022) Brain region-specific microglial and astrocytic activation in response to systemic lipopolysaccharides exposure. Front Aging Neurosci 14:910988. https://doi.org/10.3389/fnagi.2022.910988
Article CAS PubMed PubMed Central Google Scholar
Bushnell CD, Chaturvedi S, Gage KR, et al (2018) Sex differences in stroke: Challenges and opportunities. J Cereb Blood Flow Metab 38(12):2179-2191. https://doi.org/10.1177/0271678X18793324
Campbell DJ, Kladis A, Zhang Y et al (2010) Increased tissue Kallikrein levels in type 2 diabetes. Diabetologia 53:779–785. https://doi.org/10.1007/s00125-009-1645-8
Article CAS PubMed Google Scholar
Chiang W-C, Chen Y-M, Lin S-L et al (2007) Bradykinin enhances reactive oxygen species generation, mitochondrial injury, and cell death induced by ATP depletion–a role of the phospholipase C-Ca(2+) pathway. Free Radic Biol Med 43:702–710. https://doi.org/10.1016/j.freeradbiomed.2007.04.032
Article CAS PubMed Google Scholar
Denorme F, Portier I, Rustad JL et al (2022) Neutrophil extracellular traps regulate ischemic stroke brain injury. J Clin Invest 132. https://doi.org/10.1172/JCI154225
Ding-Zhou L, Margaill I, Palmier B et al (2003) LF 16–0687 Ms, a Bradykinin B 2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia. Br J Pharmacol 139:1539–1547. https://doi.org/10.1038/sj.bjp.0705385
Article CAS PubMed PubMed Central Google Scholar
Dobrivojević M, Špiranec K, Sinđić A (2015) Involvement of Bradykinin in brain edema development after ischemic stroke. Pflugers Arch 467:201–212. https://doi.org/10.1007/s00424-014-1519-x
Article CAS PubMed Google Scholar
Dobrivojević M, Špiranec K, Gorup D et al (2016) Urodilatin reverses the detrimental influence of Bradykinin in acute ischemic stroke. Exp Neurol 284:1–10. https://doi.org/10.1016/j.expneurol.2016.07.007
Article CAS PubMed Google Scholar
Duka I, Kintsurashvili E, Gavras I et al (2001) Vasoactive potential of the B1 Bradykinin receptor in normotension and hypertension. Circ Res 88:275–281. https://doi.org/10.1161/01.RES.88.3.275
Article CAS PubMed Google Scholar
Duka A, Duka I, Gao G et al (2006) Role of Bradykinin B1 and B2 receptors in normal blood pressure regulation. Am J Physiol Endocrinol Metab 291:E268–E274. https://doi.org/10.1152/ajpendo.00382.2005
Article CAS PubMed Google Scholar
Fernández-Arjona M, del Grondona M, Fernández-Llebrez JM, López-Ávalos P MD (2019) Microglial morphometric parameters correlate with the expression level of IL-1β, and allow identifying different activated morphotypes. Front Cell Neurosci 13. https://doi.org/10.3389/fncel.2019.00472
Filippenkov IB, Remizova JA, Denisova AE et al (2023) Differential gene expression in the contralateral hemisphere of the rat brain after focal ischemia. Sci Rep 13:573. https://doi.org/10.1038/s41598-023-27663-8
Article CAS PubMed PubMed Central Google Scholar
Garbuzova-Davis S, Rodrigues MCO, Hernandez-Ontiveros DG et al (2013) Blood-brain barrier alterations provide evidence of subacute Diaschisis in an ischemic stroke rat model. PLoS ONE 8:e63553. https://doi.org/10.1371/journal.pone.0063553
Article CAS PubMed PubMed Central Google Scholar
Garcia JH, Wagner S, Liu KF, Hu XJ (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26:627–634 discussion 635. https://doi.org/10.1161/01.str.26.4.627
Article CAS PubMed Google Scholar
Göb E, Reymann S, Langhauser F et al (2015) Blocking of plasma Kallikrein ameliorates stroke by reducing thromboinflammation. Ann Neurol 77:784–803. https://doi.org/10.1002/ana.24380
Article CAS PubMed Google Scholar
Gregnani MF, Hungaro TG, Martins-Silva L et al (2020) Bradykinin B2 receptor signaling increases glucose uptake and oxidation: evidence and open questions. Front Pharmacol 11:1162. https://doi.org/10.3389/fphar.2020.01162
Article CAS PubMed PubMed Central Google Scholar
Gröger M, Lebesgue D, Pruneau D et al (2005) Release of Bradykinin and expression of Kinin B 2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:978–989. https://doi.org/10.1038/sj.jcbfm.9600096
Article CAS PubMed Google Scholar
Hedeker D, Gibbons RD, Waternaux C (1999) Sample size Estimation for longitudinal designs with attrition: comparing Time-Related contrasts between two groups. J Educational Behav Stat 24:70–93. https://doi.org/10.3102/10769986024001070
Hsieh C-F, Liu C-K, Lee C-T et al (2019) Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation. Sci Rep 9:840. https://doi.org/10.1038/s41598-018-37215-0
Article CAS PubMed PubMed Central Google Scholar
Jaffa AA, Jaffa MA, Moussa M et al (2021) Modulation of Neuro-Inflammatory signals in microglia by plasma prekallikrein and neuronal cell debris. Front Pharmacol 12. https://doi.org/10.3389/fphar.2021.743059
Ji B, Cheng B, Pan Y et al (2017) Neuroprotection of bradykinin/bradykinin B2 receptor system in cerebral ischemia. Biomed Pharmacother 94:1057–1063. https://doi.org/10.1016/j.biopha.2017.08.042
Article CAS PubMed Google Scholar
Justić H, Barić A, Šimunić I et al (2022) Redefining the Koizumi model of mouse cerebral ischemia: A comparative longitudinal study of cerebral and retinal ischemia in the Koizumi and longa middle cerebral artery occlusion models. J Cereb Blood Flow Metab 42:2080–2094. https://doi.org/10.1177/0271678X221109873
Article PubMed PubMed Central Google Scholar
Justić H, Barić A, Ratko M et al (2025) The Temporal dynamic of Bradykinin type 2 receptor effects reveals its neuroprotective role in the chronic phase of cerebral and retinal ischemic injury. J Cereb Blood Flow Metabolism 45:153–170. https://doi.org/10.1177/0271678X241270241
Kalani A, Kamat PK, Tyagi N (2015) Diabetic stroke severity: epigenetic remodeling and Neuronal, Glial, and vascular dysfunction. Diabetes 64:4260–4271. https://doi.org/10.2337/db15-0422
Article CAS PubMed PubMed Central Google Scholar
Kanashiro A, Hiroki CH, da Fonseca DM et al (2020) The role of neutrophils in neuro-immune modulation. Pharmacol Res 151:104580. https://doi.org/10.1016/j.phrs.2019.104580
Article CAS PubMed Google Scholar
Kumari R, Bettermann K, Willing L et al (2020) The role of neutrophils in mediating stroke injury in the diabetic db/db mouse brain following hypoxia-ischemia. Neurochem Int 139:104790. https://doi.org/10.1016/j.neuint.2020.104790
Article CAS PubMed Google Scholar
Leeb-Lundberg LMF, Marceau F, Müller-Esterl W et al (2005) International union of Pharmacology. XLV. Classification of the Kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27–77. https://doi.org/10.1124/pr.57.1.2
Article CAS PubMed Google Scholar
Li L, Cheng S-Q, Sun Y-Q et al (2023) Resolvin D1 reprograms energy metabolism to promote microglia to phagocytize neutrophils after ischemic stroke. Cell Rep 42:112617. https://doi.org/10.1016/j.celrep.2023.112617
Comments (0)